Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future — Agnieszka Łoboda (2020) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
Shared by
Jozef Dulak
Jagiellonian University Cracow
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
Article
2020
en
Authors
AŁ
Agnieszka Łoboda
Jozef Dulak
Jagiellonian University Cracow
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
Katarzyna Kaziród
,
Małgorzata Myszka
,
Jozef Dulak
,
Agnieszka Łoboda
Article
2019
Targeting angiogenesis in Duchenne muscular dystrophy
Paulina Podkalicka
,
Olga Mucha
,
Jozef Dulak
,
Agnieszka Łoboda
Article
2025
Cell therapy for Duchenne muscular dystrophy: promises, challenges, and controversies
Agnieszka Łoboda
,
Jozef Dulak
Article
2021
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
Olga Mucha
,
Paulina Podkalicka
,
Katarzyna Kaziród
,
Emilia Samborowska
,
Jozef Dulak
,
Agnieszka Łoboda
Article
2024
432P Hydrogen sulfide attenuates skeletal muscle abnormalities in a murine model of Duchenne muscular dystrophy
Agnieszka Łoboda
,
Małgorzata Myszka
,
Olga Mucha
,
Kalina Hajok
,
Ewa Jakubczak
,
Urszula Waśniowska
,
Jozef Dulak
.webp)
Discussion(0)
No comments yet. Be the first to comment.